CLINICAL INVESTIGATION OF EA 1729

Abstract

EA 1729 (lysergic acid diethylamide, LSD25) has been studied extensively in animals and in humans as a possible incapacitating CW compound. Clinical, physiological, and psychiatric studies have been conducted. From the standpoint of biological effectiveness, EA 1729 incapacitates man at doses as low as 1 microgram/kg, the degree of incapacitation increasing with the dose. Its effects endure for periods ranging from 6 to 24 hours. There is a very wide margin of safety between the incapacitating and lethal doses.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 1961
Accession Number
AD0323701

Entities

People

  • Van M. Sim

Organizations

  • Edgewood Chemical Biological Center

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Alkaloids
  • Brain
  • Cardiovascular Physiological Phenomena
  • Chemical Synthesis
  • Chemistry
  • Drug Abuse
  • Health Services
  • Heart Rate
  • Lethal Dosage
  • Lysergic Acids
  • Medical Personnel
  • Warfare

Fields of Study

  • Medicine

Readers

  • Toxicology/Environmental Toxicology